BRPF1 and central nervous system cancer: To investigate the drug target potential of BRPF1 in glioma, we selected the BRPF1-specific inhibitor GSK6853 to treat U87-MG and U251 glioma cell lines and determined the IC50 value of GSK6853 by CCK-8 assay.